Terms: = Cervical cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
31 results:
1. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
Chen J; Pang L; He L; Li T; Cheng X
Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
[TBL] [Abstract] [Full Text] [Related]
2. Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
Yang X; Sun F; Gao Y; Li M; Liu M; Wei Y; Jie Q; Wang Y; Mei J; Mei J; Ma L; Shi Y; Chen M; Li Y; Li Q; Liu M; Ma Y
J Exp Clin Cancer Res; 2023 Oct; 42(1):268. PubMed ID: 37845756
[TBL] [Abstract] [Full Text] [Related]
3. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
[TBL] [Abstract] [Full Text] [Related]
4. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract] [Full Text] [Related]
5. Mutation Analysis of Radioresistant Early-Stage cervical cancer.
Oike T; Sekiguchi Y; Yoshimoto Y; Oike T; Ando K; Gu W; Sasaki Y; Tokino T; Iwase A; Ohno T
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008475
[TBL] [Abstract] [Full Text] [Related]
6. Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma.
Zhang M; Kiyono T; Aoki K; Goshima N; Kobayashi S; Hiranuma K; Shiraishi K; Saya H; Nakahara T
Cancer Sci; 2022 Mar; 113(3):904-915. PubMed ID: 34932848
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical Loss of dpc4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract.
Kwon DH; Malpica A; Zaleski M; Euscher ED; Ramalingam P
Int J Gynecol Pathol; 2021 Nov; 40(6):523-532. PubMed ID: 33405429
[TBL] [Abstract] [Full Text] [Related]
8. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
[TBL] [Abstract] [Full Text] [Related]
9. TGFBR2 Regulates Hedgehog Pathway and cervical cancer Cell Proliferation and Migration by Mediating smad4.
Yuan J; Yi K; Yang L
J Proteome Res; 2020 Aug; 19(8):3377-3385. PubMed ID: 32628850
[TBL] [Abstract] [Full Text] [Related]
10. Expression of smad4 is Retained in Most Gynecologic Tumors with Mucinous Differentiation.
Alghamdi S; Alghaashamy K; Pinto A
Int J Gynecol Pathol; 2020 Sep; 39(5):493-497. PubMed ID: 31569186
[TBL] [Abstract] [Full Text] [Related]
11. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract] [Full Text] [Related]
12. Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in cervical cancer Cells by Targeting smad4.
Phuah NH; Azmi MN; Awang K; Nagoor NH
Mol Cells; 2017 Apr; 40(4):291-298. PubMed ID: 28401751
[TBL] [Abstract] [Full Text] [Related]
13. Let‑7a suppresses cell proliferation via the TGF‑β/SMAD signaling pathway in cervical cancer.
Wu T; Chen X; Peng R; Liu H; Yin P; Peng H; Zhou Y; Sun Y; Wen L; Yi H; Li A; Zhang Z
Oncol Rep; 2016 Dec; 36(6):3275-3282. PubMed ID: 27748903
[TBL] [Abstract] [Full Text] [Related]
14. ANXA1Ac₂₋₂₆ peptide reduces ID1 expression in cervical carcinoma cultures.
Prates J; Franco-Salla GB; Dinarte Dos Santos AR; da Silva WA; da Cunha BR; Tajara EH; Oliani SM; Rodrigues-Lisoni FC
Gene; 2015 Oct; 570(2):248-54. PubMed ID: 26072160
[TBL] [Abstract] [Full Text] [Related]
15. [Gynecologic cancers in a hospital: a retrospective analysis of admission data over ten years].
Chen MQ; Gong MQ; Gao HC; Gao XM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):326-30. PubMed ID: 25924453
[TBL] [Abstract] [Full Text] [Related]
16. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract] [Full Text] [Related]
17. Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition.
Chaudhry P; Fabi F; Singh M; Parent S; Leblanc V; Asselin E
Cell Death Dis; 2014 Feb; 5(2):e1044. PubMed ID: 24503536
[TBL] [Abstract] [Full Text] [Related]
18. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
Altomare D; Velidandla R; Pirisi L; Creek KE
BMC Cancer; 2013 Sep; 13():424. PubMed ID: 24047375
[TBL] [Abstract] [Full Text] [Related]
19. Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway.
French D; Belleudi F; Mauro MV; Mazzetta F; Raffa S; Fabiano V; Frega A; Torrisi MR
Mol Cancer; 2013 May; 12():38. PubMed ID: 23651589
[TBL] [Abstract] [Full Text] [Related]
20. Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer.
Noordhuis MG; Fehrmann RS; Wisman GB; Nijhuis ER; van Zanden JJ; Moerland PD; Ver Loren van Themaat E; Volders HH; Kok M; ten Hoor KA; Hollema H; de Vries EG; de Bock GH; van der Zee AG; Schuuring E
Clin Cancer Res; 2011 Mar; 17(6):1317-30. PubMed ID: 21385933
[TBL] [Abstract] [Full Text] [Related]
[Next]
